Research Article
Alterations of the Bile Microbiome in Recurrent Common Bile Duct Stone
Table 1
Baseline characteristics of patients in the recurrence group and the control group.
| | Characteristic | Recurrence group | Control group | value |
| | Patients, | 27 | 19 | NA | | Male, (%) | 17 (63%) | 11 (57.9%) | 0.767 | | Age (years) | 62 (34-90) | 53 (14-78) | 0.010 | | BMI (kg/m2) | 24.6 (18.9-33.7) | 23.4 (19.1-32.3) | 0.065 | | TBIL (μmol/L) | 34.1 (9.2-183.6) | 24.1 (11.9-443.2) | 0.260 | | AST (U/L) | 33.2 (10.2-388.7) | 28.1 (15.3-295.7) | 0.538 | | ALT (U/L) | 71.5 (5.3-641.1) | 74.7 (11.2-308.6) | 0.378 | | ALP (U/L) | 157.1 (46.5-881.9) | 81.4 (50.2-896.5) | 0.631 | | GGT (U/L) | 168.6 (14.7-1054.2) | 41.9 (13.8-791) | 0.259 | | WBC (109/L) | 7.7 (1.6-24.8) | 5.7 (2.8-10.2) | 0.199 | | Previous ERCP, (%) | 17 (74.1%) | 2 (10.5%) | 0.001 | | Previous EST, (%) | 12 | 0 | <0.001 | | Previous cholecystectomy, (%) | 22 (81.5%) | 2 (10.5%) | <0.001 | | Previous bile duct surgery, (%) | 13 (48.1%) | 0 | <0.001 | | Mean recurrence time (year) | 2 (0.5-20) | NA | NA |
|
|
BMI: body mass index; TBIL: total bilirubin; AST: aspartate aminotransferase; ALT: alanine aminotransferase; ALP: alkaline phosphatase; GGT: gamma-glutamyl transpeptidase; WBC: white blood cell; ERCP: endoscopic retrograde cholangiopancreatography; EST: endoscopic sphincterotomy; NA: not available.
|
